ASSOCIATION OF SODIUM/GLUCOSE COTRANSPORTER-2 INHIBITORS WITH OUTCOMES IN PATIENTS WITH TYPE 2 DIABETES AND ATRIAL FIBRILLATION

被引：0
|
作者：
Brewerton, Annie
Abdel-Qadir, Husam Mohamed
Ko, Dennis T.
Lee, Douglas
Singh, Sheldon M. S.
Jackevicius, Cynthia
Dorian, Paul
Austin, Peter
Han, Lu
Lega, Iliana
机构：
[1] Womens Coll Hosp, Toronto, ON, Canada
[2] Univ Toronto, Toronto, ON, Canada
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2022年 / 79卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1527 / 1527
页数：1
相关论文
共 50 条
  • [1] Effects of sodium-glucose cotransporter-2 inhibitors on cardiovascular outcomes in patients with atrial fibrillation and type 2 diabetes mellitus
    Oh, Y. S.
    Choi, Y.
    Kim, S. H.
    Kim, S. H.
    Park, S. Y.
    Kim, H. J.
    EUROPEAN HEART JOURNAL, 2023, 44
  • [2] Association of Sodium-Glucose Cotransporter-2 Inhibitors With Incident Atrial Fibrillation in Older Adults With Type 2 Diabetes
    Zhuo, Min
    D'Andrea, Elvira
    Paik, Julie M.
    Wexler, Deborah J.
    Everett, Brendan M.
    Glynn, Robert J.
    Kim, Seoyoung C.
    Patorno, Elisabetta
    JAMA NETWORK OPEN, 2022, 5 (10) : E2235995
  • [3] Cardiovascular outcomes of sodium glucose cotransporter-2 inhibitors in patients with type 2 diabetes
    Dawwas, Ghadeer K.
    Smith, Steven M.
    Park, Haesuk
    DIABETES OBESITY & METABOLISM, 2019, 21 (01): : 28 - 36
  • [4] Association between sodium-glucose cotransporter-2 inhibitors and arrhythmic outcomes in patients with diabetes and pre-existing atrial fibrillation
    Fichadiya, Akash
    Quinn, Amity
    Au, Flora
    Campbell, Dennis
    Lau, Darren
    Ronksley, Paul
    Beall, Reed
    Campbell, David J. T.
    Wilton, Stephen B.
    Chew, Derek S.
    EUROPACE, 2024, 26 (03):
  • [5] Sodium-Glucose Cotransporter-2 Inhibitors and the Risk of Incident Atrial Fibrillation in Older Adults with Type 2 Diabetes
    Zhuo, Min
    Paik, Julie M.
    Wexler, Deborah J.
    Everett, Brendan M.
    D'Andrea, Elvira
    Glynn, Robert
    Kim, Seoyoung C.
    Patorno, Elisabetta
    DIABETES, 2022, 71
  • [6] Effects of Sodium-Glucose Cotransporter-2 Inhibitors on the Risk of Atrial Fibrillation in Older Adults with Type 2 Diabetes
    Li, Yujia
    Guo, Yi
    Kimmel, Stephen
    Bian, Jiang
    Schatz, Desmond
    Guo, Jingchuan
    DIABETES, 2023, 72
  • [7] Sodium-glucose cotransporter-2 inhibitors had a significant association with less atrial fibrillation
    Xiao, Yu
    Liu, Chao
    EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2024, 31 (07) : e53 - e54
  • [8] Effect of sodium glucose cotransporter-2 inhibitors (SGLT-2is) on the clinical outcomes of patients with diabetic atrial fibrillation
    Aydemir, Selim
    Aydin, Sidar Siyar
    Aksakal, Emrah
    Altinkaya, Onur
    Ozmen, Murat
    Birdal, Oguzhan
    BMC CARDIOVASCULAR DISORDERS, 2024, 24 (01):
  • [9] Effects of Sodium-Glucose Cotransporter-2 Inhibitors and Thiazolidinedione on New-Onset Atrial Fibrillation Risk to Patients with Type 2 Diabetes
    Song, Haegeun
    Kim, Yoo Ri
    Lee, Seung Eun
    Nam, Hyewon
    Kim, Hoseob
    Kyoung, Dae-Sung
    Kim, Kyoung-Ah
    REVIEWS IN CARDIOVASCULAR MEDICINE, 2022, 23 (09)
  • [10] Sodium-glucose cotransporter-2 inhibitors and the risk of atrial fibrillation in patients with type 2 diabetes: a population-based cohort study
    Eroglu, Talip E.
    Coronel, Ruben
    Souverein, Patrick C.
    EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 2024, 10 (04) : 289 - 295
12345